Malaria vaccines—now and the future
- 1 November 1995
- journal article
- review article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 89 (6) , 585-587
- https://doi.org/10.1016/0035-9203(95)90399-2
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- A pilot safety and immunogenicity study of the malaria vaccine SPf66 in Gambian infantsParasite Immunology, 1995
- Safety, Immunogenicity, and Efficacy of a Recombinantly Produced Plasmodium falciparum Circumsporozoite Protein-Hepatitis B Surface Antigen Subunit VaccineThe Journal of Infectious Diseases, 1995
- Predicted disulfide-bonded structures for three uniquely related proteins of Plasmodium falciparum, Pfs230, Pfs4845 and Pf12Molecular and Biochemical Parasitology, 1995
- SPf66 - The first malaria vaccineParasitology Today, 1995
- Safety, immunogenicity and limited efficacy study of a recombinant Plasmodium falciparum circumsporozoite vaccine in Thai soldiersVaccine, 1994
- Transmission-blocking immunity against malaria and other vector-borne diseasesCurrent Opinion in Immunology, 1993
- ‘Original antigenic sin’, T cell memory, and malaria sporozoite immunity: an hypothesis for immune evasionParasite Immunology, 1993
- Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in ColombiaThe Lancet, 1993
- Molecular analysis of the association of HLA-B53 and resistance to severe malariaNature, 1992
- Common West African HLA antigens are associated with protection from severe malariaNature, 1991